Respiratory syncytial virus immune globulinAlternative Names: Hypermune RSV; RespiGam; Respiratory syncytial virus immune globulin intravenous; RSV immunoglobulin; RSV-IGIV
Latest Information Update: 21 Jun 2007
At a glance
- Originator MedImmune
- Class Antivirals; Immunoglobulins
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Marketed Respiratory syncytial virus infections